辅助CMF化疗治疗乳腺癌的案例。制作好了吗?

Cancer clinical trials Pub Date : 1981-01-01

S H Levitt, R A Potish

{"title":"辅助CMF化疗治疗乳腺癌的案例。制作好了吗?","authors":"S H Levitt, R A Potish","doi":"","DOIUrl":null,"url":null,"abstract":"The utility of adjuvant CMF in the treatment of breast cancer has been reanalyzed. The actual percentage of patients who benefit from adjuvant CMF has been shown to be relatively small. The widespread use of adjuvant CMF must be further examined.","PeriodicalId":75672,"journal":{"name":"Cancer clinical trials","volume":"4 4","pages":"363-9"},"PeriodicalIF":0.0000,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?\",\"authors\":\"S H Levitt, R A Potish\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The utility of adjuvant CMF in the treatment of breast cancer has been reanalyzed. The actual percentage of patients who benefit from adjuvant CMF has been shown to be relatively small. The widespread use of adjuvant CMF must be further examined.\",\"PeriodicalId\":75672,\"journal\":{\"name\":\"Cancer clinical trials\",\"volume\":\"4 4\",\"pages\":\"363-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1981-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer clinical trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer clinical trials","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

辅助CMF在乳腺癌治疗中的应用已被重新分析。从辅助CMF中获益的患者的实际百分比已被证明相对较小。辅助CMF的广泛使用必须进一步研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?

The utility of adjuvant CMF in the treatment of breast cancer has been reanalyzed. The actual percentage of patients who benefit from adjuvant CMF has been shown to be relatively small. The widespread use of adjuvant CMF must be further examined.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer clinical trials

自引率

0.00%

发文量